Pharmacological characterization of the sodium-glicose co-transporter 2 inhibitors, gliflozins in isolated platelets from healthy volunteers

Gliflozins are a new pharmacological class of drug approved to treating patients with type 2 diabetes and act by inhibiting the sodium-glucose co-transporter 2 (SGLT2) on the epithelial cells of the proximal convoluted tubule of the kidneys. Cardiovascular diseases (CVDs) are a major challenge in th...

Full description

Bibliographic Details

Main Authors:	Torres, Pedro Henrique Portugal, Iglesias, Fabiola Taufic Monica, Lescano, Caroline Honaiser
Format:	Online
Language:	English
Published:	Universidade Estadual de Campinas 2019
Subjects:	Platelets Empagliflozin Aggregation Dapagliflozin Canagliflozin.
Online Access:	https://econtents.sbu.unicamp.br/eventos/index.php/pibic/article/view/1140
Tags:	Add Tag No Tags, Be the first to tag this record!